AVECHO BIOTECHNOLOGY LIMITED - Announcements

0.00%

0.6¢

Market Cap $19.04M

Healthcare Biotechnology

Avecho Biotechnology Limited is an Australia-based biopharmaceutical company. The Company... Avecho Biotechnology Limited is an Australia-based biopharmaceutical company. The Company develops and commercializes human and animal health products using its drug delivery system called Tocopheryl Phosphate Mixture (TPM). TPM is derived from vitamin E using patented processes. The Company's segments include Production and Human Health. The Production segment manufactures and sells TPM and Vital ET for use in drug delivery and cosmetic formulations. The Human Health portfolio covers delivery of pharmaceutical products through gels, injectables and patches, including conduct of research and development activities. The Company's products pipeline includes Weaner Pig Starter TPM Premix, Poultry TPM Premix, Dairy TPM Premix, Daptomycin, Propofol and Veterinary Applications. The Company is also developing TPM to enhance feed efficiency and the health of livestock. Its TPM products are commercialized under license: Voveran TPM Gel, Instanac TPM Gel, Vital ET, and Ashland TPM. More

HELPING PATIENTS ON THEIR JOURNEY TO BETTER HEALTH

Little Green Pharma (ASX:LGP) to benefit as Denmark commits to cannabis pilot program.

Announcements

Filter Results

All Price Sensitive Only

AVE	Trading Halt	PRICE SENSITIVE	09/07/14	181.95KB	Share
AVE	Strengthens Partnership with Le Metier de Beaute Cosmetics		12/06/14	42.89KB	Share
AVE	Appendix 3Y Notices -3- Change in Directors Interest		03/06/14	232.62KB	Share
AVE	Appendix 3B Notice - Issue of Options to Directors		03/06/14	320.17KB	Share
AVE	2014 AGM Results		23/05/14	671.21KB	Share
AVE	2014 AGM Addresses - Presentations		23/05/14	1.06MB	Share
AVE	POH Topical Oxycodone Patch Alleviates Pain in Racehorses	PRICE SENSITIVE	21/05/14	321.98KB	Share
AVE	POH Presents Transdermal Oxymorphone Data in USA		05/05/14	594.4KB	Share
AVE	Enrolments Completed for Phase 2 Acne Treatment Trial	PRICE SENSITIVE	23/04/14	118.43KB	Share
AVE	2013 Annual Report and 2014 AGM Documentation		17/04/14	3.66MB	Share
AVE	Webcast Investment Presentation		03/04/14	822.9KB	Share
AVE	March 2014 NEWSLETTER		17/03/14	1.39MB	Share
AVE	Appendix 3X and Appendix 3Y Notices		04/03/14	302.1KB	Share
AVE	Appointment of Non-Executive Directors		03/03/14	45.55KB	Share
AVE	December 2013 Appendix 4E - Annual Financial Report	PRICE SENSITIVE	28/02/14	428.03KB	Share
AVE	Novartis Launches Voveran TPM Gel in India	PRICE SENSITIVE	21/01/14	57.28KB	Share
AVE	Reconciliation of Non-Quoted Securities - Conditional Rights		20/12/13	270.98KB	Share
AVE	Phosphagenics - TPM in Dairy Feed Inclusion Technology	PRICE SENSITIVE	12/12/13	144.76KB	Share
AVE	POH Signs Further Deed of Settlement with Final Parties	PRICE SENSITIVE	08/11/13	126.45KB	Share
AVE	Phosphagenics Issues Proceedings Against Former Employee		31/10/13	37.98KB	Share
AVE	Phosphagenics Signs Deed of Settlement with Dr Ogru	PRICE SENSITIVE	30/10/13	186.67KB	Share
AVE	Phosphagenics' Oxymorphone Patch Success	PRICE SENSITIVE	24/10/13	48.29KB	Share
AVE	Oxymorphone Pain Relief Patch - Multi-Dose Trial	PRICE SENSITIVE	19/09/13	170.16KB	Share
AVE	September 2013 Newsletter		10/09/13	5.81MB	Share
AVE	Reconciliation of Non-Quoted Securities		04/09/13	167.72KB	Share
AVE	POH - TPM Drug Delivery Technology - PAINWeek 2013 in USA		03/09/13	41.27KB	Share
AVE	June 2013 Appendix 4D Half Year Financial Report - Accounts	PRICE SENSITIVE	30/08/13	767.23KB	Share
AVE	Sale of Former CEO Shares		05/08/13	36.38KB	Share
AVE	Phosphagenics Pain Program Update	PRICE SENSITIVE	26/07/13	46.41KB	Share
AVE	Misappropriations Investigation - Clarification		25/07/13	135.79KB	Share
AVE	Appendix 3Z Final Director's Interest Notice - Dr E Ogru		24/07/13	275.37KB	Share
AVE	Invoicing and Accounting Misappropriations Investigation	PRICE SENSITIVE	24/07/13	42.12KB	Share
AVE	Resignation of Executive Director		22/07/13	36.9KB	Share
AVE	Phosphagenics to Launch Phase 2 Acne Treatment Trial	PRICE SENSITIVE	12/07/13	144.21KB	Share
AVE	Invoicing and Accounting Irregularities	PRICE SENSITIVE	01/07/13	38.96KB	Share
AVE	Trading Halt	PRICE SENSITIVE	28/06/13	129.24KB	Share
AVE	Asia Biotech Invest 2013 Conference POH Presentation		04/06/13	2.93MB	Share
AVE	R & D Taxation Incentive	PRICE SENSITIVE	28/05/13	39.37KB	Share
AVE	May 2013 NEWSLETTER		22/05/13	497.56KB	Share
AVE	Phosphagenics AGM - Results of Meeting		17/05/13	28.43KB	Share
AVE	Phosphagenics - AGM - CEO Presentation		17/05/13	1.46MB	Share
AVE	POH signs Agreement with Agricultural Research Service	PRICE SENSITIVE	14/05/13	138.83KB	Share
AVE	Appendix 3Y - Directors Change in Interest in Securities		09/05/13	603.46KB	Share
AVE	Appendix 3Y - Change in Interest in Securities		07/05/13	618.02KB	Share
AVE	Appendix 3Y - Change in Directors Interest Notice		24/04/13	605.88KB	Share
AVE	POH Annual Report and AGM Documentation		15/04/13	3.68MB	Share
AVE	TPM/Diclofenac Gel - Themis in Supply Agmt with Novartis	PRICE SENSITIVE	15/04/13	45.39KB	Share
AVE	Appendix 3Y - Change of Directors Interest Notice		09/04/13	751.38KB	Share
AVE	Appendix 3B - Reconciliation of Issued Securities		08/04/13	547.67KB	Share
AVE	Appendix 3Y Notice - Change Direcror's Interest		08/04/13	133.45KB	Share
AVE	Oxymorphone Patch Meets Phase 1 End Points	PRICE SENSITIVE	25/03/13	139.69KB	Share
TSN +AHE AIA AKM ALU AMA RCM APK A1N AQP ARH ARU ATI AUC AVB AYN AZM BCI BGL BTU BVA BRV CDA CFU CGH CJO CKA CLH CLO CLR CLX CMW CNX CTP CYG DMG DMP DNA EGN ELD SKS FAR FND FSF TOY FXJ GAP GBG GEM GOR GRY GXL HCH NGI HHL HIG HZN A1M ICN IDC IFM INA IRD IRI IRN JIN JPR KGD KGL LIC LNG FUN LSA MEL MEO MFG MIN ASL MMX MOL MOY MRP MTE MVP MXI MYX NGF NKP ACF NSE OEL ONT PCL OVT PMV AVE PPG RCT NMT REA RFG RIA RIC ROL RQL SAR SEH SGN SIH SIR SIV SMR SSM STB STX PRM SWL SYR TAM TBR TME TOE PAC UBI UML UNS URF UXC VOC THB WCL WDS WLL WTP YAL YTC ZSP	S&P DJ Indices Announces March Quarterly Rebalance		01/03/13	80.22KB	Share
AVE	Phosphagenics Further Expands Pain Portfolio	PRICE SENSITIVE	20/02/13	47.73KB	Share
AVE	December 2012 Appendix 4E and Audited Financial Report	PRICE SENSITIVE	19/02/13	1.54MB	Share
AVE	Oxycodone Patch Update	PRICE SENSITIVE	11/02/13	45.21KB	Share
AVE	POH - February 2013 Newsletter		01/02/13	2.26MB	Share
AVE	POH Initiates Clinical Program with Oxymorphone TPM Patch	PRICE SENSITIVE	16/01/13	51.24KB	Share
AVE	Phosphagenics to Supply Firming Cream to GNC	PRICE SENSITIVE	05/12/12	47.51KB	Share
AVE	Oxycodone Patch Update - Development and Product Expansion	PRICE SENSITIVE	03/12/12	49.33KB	Share
AVE	Reconciliation - Non-Quoted Conditional Rights		16/11/12	208.88KB	Share
AVE	POH in JV to Supply TPM Equine Supplements to Golbal Market	PRICE SENSITIVE	31/10/12	46.61KB	Share
AVE	POH Licences TPM Platform to Indian Pharmaceutical Company	PRICE SENSITIVE	30/10/12	57.59KB	Share
AVE	Presentation - Macquarrie Emerging Healthcare Conference		10/10/12	935.12KB	Share
AVE	September 2012 Newsletter		26/09/12	2.75MB	Share
AVE	June 2012 Half Yearly Report and Financial Report	PRICE SENSITIVE	20/08/12	575.58KB	Share
AVE	Neura Therapeutik Appointed as US Strategic Advisors	PRICE SENSITIVE	01/08/12	48.45KB	Share
AVE	Phosphagenics to Develop Racehorse Supplements		29/06/12	46.51KB	Share
AVE	POH - June 2012 Newsletter		26/06/12	363.06KB	Share
AVE	Australian Life Sciences Investment Showcase in New York		15/06/12	3.55MB	Share
AVE	Expiry Non-Quoted ESOP Options - POHAQ		07/06/12	21.12KB	Share
AVE	POH Further Refinements to Oxycodone Patch Design	PRICE SENSITIVE	05/06/12	44.88KB	Share
AVE	Annual General Meeting - Results of Meeting		24/05/12	28.11KB	Share
AVE	POH - AGM Chairman's Address and CEO Presentation		24/05/12	539.88KB	Share
AVE	CEO Presentation - Bell Potter Life Sciences Conference		23/05/12	983.55KB	Share
AVE	Phosphagenics Engages Labtec for Final Patch Design		23/05/12	41.34KB	Share
AVE	POH adds David Jones as retail partner for Elixia products	PRICE SENSITIVE	08/05/12	38.74KB	Share
AVE	App3B - Exercise Options - Reconcilation Non-listed security		04/05/12	321.79KB	Share
AVE	Annual Report and Notice of AGM - Proxy Form		20/04/12	2.06MB	Share
AVE	Phosphagenics -Newsletter April 2012		11/04/12	681.83KB	Share
AVE	POH Signs License Agreement with Intas Pharmaceuticals	PRICE SENSITIVE	04/04/12	143.78KB	Share
AVE	Change in substantial holding		22/03/12	88.5KB	Share
AVE	Change in substantial holding		15/03/12	88.3KB	Share
AVE	Korean Distribution Agreement for BioElixia	PRICE SENSITIVE	15/03/12	41.19KB	Share
AVE	Change in substantial holding		06/03/12	88.25KB	Share
AVE	POH signs Agreement with Japanese Pharmaceutical Company	PRICE SENSITIVE	05/03/12	57.18KB	Share
AVE	Ceasing to be a substantial holder		23/02/12	55.36KB	Share
AVE	December 2011 Preliminary Final and Audited Financial Report	PRICE SENSITIVE	21/02/12	1013.91KB	Share
AVE	Change in substantial holding		17/02/12	88.78KB	Share
AVE	Delivery of Further Positive Oxycodone Patch Trial Results	PRICE SENSITIVE	15/02/12	46.13KB	Share
AVE	Substantial Shareholding Notices - Form 605 and Form 604		01/02/12	1.26MB	Share
AVE	Change in substantial holding		16/12/11	90.85KB	Share
AVE	Equity Raising correction re issue price		14/12/11	38.71KB	Share
AVE	December 2011 eNewsletter and Placement of Shares		14/12/11	1.71MB	Share
AVE	General Meeting Results and CEO Presentation		09/12/11	948.29KB	Share
AVE	Change of Director's Interest Notice (3)		28/11/11	100.95KB	Share
AVE	Pivotal TPM-oxycodone Patch Trials Begin	PRICE SENSITIVE	21/11/11	45.86KB	Share
AVE	Share Purchase Plan - Quotation os Shares and Refunds		16/11/11	33.57KB	Share
AVE	Share Purchase Plan Heavily Oversubscribed		14/11/11	45.56KB	Share
AVE	Notice of General Meeting and Proxy Form - 09 12 2011		03/11/11	612.85KB	Share
AVE	Phosphagenics Licenses Diclofenac Gel for Indian Market	PRICE SENSITIVE	02/11/11	42.33KB	Share

AVE Trading Halt
09/07/14	PRICE SENSITIVE	181.95KB	Share
AVE Strengthens Partnership with Le Metier de Beaute Cosmetics
12/06/14		42.89KB	Share
AVEAppendix 3Y Notices -3- Change in Directors Interest
03/06/14		232.62KB	Share
AVEAppendix 3B Notice - Issue of Options to Directors
03/06/14		320.17KB	Share
AVE2014 AGM Results
23/05/14		671.21KB	Share
AVE2014 AGM Addresses - Presentations
23/05/14		1.06MB	Share
AVEPOH Topical Oxycodone Patch Alleviates Pain in Racehorses
21/05/14	PRICE SENSITIVE	321.98KB	Share
AVEPOH Presents Transdermal Oxymorphone Data in USA
05/05/14		594.4KB	Share
AVEEnrolments Completed for Phase 2 Acne Treatment Trial
23/04/14	PRICE SENSITIVE	118.43KB	Share
AVE2013 Annual Report and 2014 AGM Documentation
17/04/14		3.66MB	Share
AVEWebcast Investment Presentation
03/04/14		822.9KB	Share
AVEMarch 2014 NEWSLETTER
17/03/14		1.39MB	Share
AVEAppendix 3X and Appendix 3Y Notices
04/03/14		302.1KB	Share
AVEAppointment of Non-Executive Directors
03/03/14		45.55KB	Share
AVEDecember 2013 Appendix 4E - Annual Financial Report
28/02/14	PRICE SENSITIVE	428.03KB	Share
AVENovartis Launches Voveran TPM Gel in India
21/01/14	PRICE SENSITIVE	57.28KB	Share
AVEReconciliation of Non-Quoted Securities - Conditional Rights
20/12/13		270.98KB	Share
AVEPhosphagenics - TPM in Dairy Feed Inclusion Technology
12/12/13	PRICE SENSITIVE	144.76KB	Share
AVEPOH Signs Further Deed of Settlement with Final Parties
08/11/13	PRICE SENSITIVE	126.45KB	Share
AVEPhosphagenics Issues Proceedings Against Former Employee
31/10/13		37.98KB	Share
AVEPhosphagenics Signs Deed of Settlement with Dr Ogru
30/10/13	PRICE SENSITIVE	186.67KB	Share
AVEPhosphagenics' Oxymorphone Patch Success
24/10/13	PRICE SENSITIVE	48.29KB	Share
AVEOxymorphone Pain Relief Patch - Multi-Dose Trial
19/09/13	PRICE SENSITIVE	170.16KB	Share
AVESeptember 2013 Newsletter
10/09/13		5.81MB	Share
AVEReconciliation of Non-Quoted Securities
04/09/13		167.72KB	Share
AVEPOH - TPM Drug Delivery Technology - PAINWeek 2013 in USA
03/09/13		41.27KB	Share
AVEJune 2013 Appendix 4D Half Year Financial Report - Accounts
30/08/13	PRICE SENSITIVE	767.23KB	Share
AVESale of Former CEO Shares
05/08/13		36.38KB	Share
AVEPhosphagenics Pain Program Update
26/07/13	PRICE SENSITIVE	46.41KB	Share
AVEMisappropriations Investigation - Clarification
25/07/13		135.79KB	Share
AVEAppendix 3Z Final Director's Interest Notice - Dr E Ogru
24/07/13		275.37KB	Share
AVEInvoicing and Accounting Misappropriations Investigation
24/07/13	PRICE SENSITIVE	42.12KB	Share
AVEResignation of Executive Director
22/07/13		36.9KB	Share
AVEPhosphagenics to Launch Phase 2 Acne Treatment Trial
12/07/13	PRICE SENSITIVE	144.21KB	Share
AVEInvoicing and Accounting Irregularities
01/07/13	PRICE SENSITIVE	38.96KB	Share
AVETrading Halt
28/06/13	PRICE SENSITIVE	129.24KB	Share
AVEAsia Biotech Invest 2013 Conference POH Presentation
04/06/13		2.93MB	Share
AVER & D Taxation Incentive
28/05/13	PRICE SENSITIVE	39.37KB	Share
AVEMay 2013 NEWSLETTER
22/05/13		497.56KB	Share
AVEPhosphagenics AGM - Results of Meeting
17/05/13		28.43KB	Share
AVEPhosphagenics - AGM - CEO Presentation
17/05/13		1.46MB	Share
AVEPOH signs Agreement with Agricultural Research Service
14/05/13	PRICE SENSITIVE	138.83KB	Share
AVEAppendix 3Y - Directors Change in Interest in Securities
09/05/13		603.46KB	Share
AVEAppendix 3Y - Change in Interest in Securities
07/05/13		618.02KB	Share
AVEAppendix 3Y - Change in Directors Interest Notice
24/04/13		605.88KB	Share
AVEPOH Annual Report and AGM Documentation
15/04/13		3.68MB	Share
AVETPM/Diclofenac Gel - Themis in Supply Agmt with Novartis
15/04/13	PRICE SENSITIVE	45.39KB	Share
AVEAppendix 3Y - Change of Directors Interest Notice
09/04/13		751.38KB	Share
AVEAppendix 3B - Reconciliation of Issued Securities
08/04/13		547.67KB	Share
AVEAppendix 3Y Notice - Change Direcror's Interest
08/04/13		133.45KB	Share
AVEOxymorphone Patch Meets Phase 1 End Points
25/03/13	PRICE SENSITIVE	139.69KB	Share
TSN +AHE AIA AKM ALU AMA RCM APK A1N AQP ARH ARU ATI AUC AVB AYN AZM BCI BGL BTU BVA BRV CDA CFU CGH CJO CKA CLH CLO CLR CLX CMW CNX CTP CYG DMG DMP DNA EGN ELD SKS FAR FND FSF TOY FXJ GAP GBG GEM GOR GRY GXL HCH NGI HHL HIG HZN A1M ICN IDC IFM INA IRD IRI IRN JIN JPR KGD KGL LIC LNG FUN LSA MEL MEO MFG MIN ASL MMX MOL MOY MRP MTE MVP MXI MYX NGF NKP ACF NSE OEL ONT PCL OVT PMV AVE PPG RCT NMT REA RFG RIA RIC ROL RQL SAR SEH SGN SIH SIR SIV SMR SSM STB STX PRM SWL SYR TAM TBR TME TOE PAC UBI UML UNS URF UXC VOC THB WCL WDS WLL WTP YAL YTC ZSPS&P DJ Indices Announces March Quarterly Rebalance
01/03/13		80.22KB	Share
AVEPhosphagenics Further Expands Pain Portfolio
20/02/13	PRICE SENSITIVE	47.73KB	Share
AVEDecember 2012 Appendix 4E and Audited Financial Report
19/02/13	PRICE SENSITIVE	1.54MB	Share
AVEOxycodone Patch Update
11/02/13	PRICE SENSITIVE	45.21KB	Share
AVEPOH - February 2013 Newsletter
01/02/13		2.26MB	Share
AVEPOH Initiates Clinical Program with Oxymorphone TPM Patch
16/01/13	PRICE SENSITIVE	51.24KB	Share
AVEPhosphagenics to Supply Firming Cream to GNC
05/12/12	PRICE SENSITIVE	47.51KB	Share
AVEOxycodone Patch Update - Development and Product Expansion
03/12/12	PRICE SENSITIVE	49.33KB	Share
AVEReconciliation - Non-Quoted Conditional Rights
16/11/12		208.88KB	Share
AVEPOH in JV to Supply TPM Equine Supplements to Golbal Market
31/10/12	PRICE SENSITIVE	46.61KB	Share
AVEPOH Licences TPM Platform to Indian Pharmaceutical Company
30/10/12	PRICE SENSITIVE	57.59KB	Share
AVEPresentation - Macquarrie Emerging Healthcare Conference
10/10/12		935.12KB	Share
AVESeptember 2012 Newsletter
26/09/12		2.75MB	Share
AVEJune 2012 Half Yearly Report and Financial Report
20/08/12	PRICE SENSITIVE	575.58KB	Share
AVENeura Therapeutik Appointed as US Strategic Advisors
01/08/12	PRICE SENSITIVE	48.45KB	Share
AVEPhosphagenics to Develop Racehorse Supplements
29/06/12		46.51KB	Share
AVEPOH - June 2012 Newsletter
26/06/12		363.06KB	Share
AVEAustralian Life Sciences Investment Showcase in New York
15/06/12		3.55MB	Share
AVEExpiry Non-Quoted ESOP Options - POHAQ
07/06/12		21.12KB	Share
AVEPOH Further Refinements to Oxycodone Patch Design
05/06/12	PRICE SENSITIVE	44.88KB	Share
AVEAnnual General Meeting - Results of Meeting
24/05/12		28.11KB	Share
AVEPOH - AGM Chairman's Address and CEO Presentation
24/05/12		539.88KB	Share
AVECEO Presentation - Bell Potter Life Sciences Conference
23/05/12		983.55KB	Share
AVEPhosphagenics Engages Labtec for Final Patch Design
23/05/12		41.34KB	Share
AVEPOH adds David Jones as retail partner for Elixia products
08/05/12	PRICE SENSITIVE	38.74KB	Share
AVEApp3B - Exercise Options - Reconcilation Non-listed security
04/05/12		321.79KB	Share
AVEAnnual Report and Notice of AGM - Proxy Form
20/04/12		2.06MB	Share
AVEPhosphagenics -Newsletter April 2012
11/04/12		681.83KB	Share
AVEPOH Signs License Agreement with Intas Pharmaceuticals
04/04/12	PRICE SENSITIVE	143.78KB	Share
AVEChange in substantial holding
22/03/12		88.5KB	Share
AVEChange in substantial holding
15/03/12		88.3KB	Share
AVEKorean Distribution Agreement for BioElixia
15/03/12	PRICE SENSITIVE	41.19KB	Share
AVEChange in substantial holding
06/03/12		88.25KB	Share
AVEPOH signs Agreement with Japanese Pharmaceutical Company
05/03/12	PRICE SENSITIVE	57.18KB	Share
AVECeasing to be a substantial holder
23/02/12		55.36KB	Share
AVEDecember 2011 Preliminary Final and Audited Financial Report
21/02/12	PRICE SENSITIVE	1013.91KB	Share
AVEChange in substantial holding
17/02/12		88.78KB	Share
AVEDelivery of Further Positive Oxycodone Patch Trial Results
15/02/12	PRICE SENSITIVE	46.13KB	Share
AVESubstantial Shareholding Notices - Form 605 and Form 604
01/02/12		1.26MB	Share
AVEChange in substantial holding
16/12/11		90.85KB	Share
AVEEquity Raising correction re issue price
14/12/11		38.71KB	Share
AVEDecember 2011 eNewsletter and Placement of Shares
14/12/11		1.71MB	Share
AVEGeneral Meeting Results and CEO Presentation
09/12/11		948.29KB	Share
AVEChange of Director's Interest Notice (3)
28/11/11		100.95KB	Share
AVEPivotal TPM-oxycodone Patch Trials Begin
21/11/11	PRICE SENSITIVE	45.86KB	Share
AVEShare Purchase Plan - Quotation os Shares and Refunds
16/11/11		33.57KB	Share
AVEShare Purchase Plan Heavily Oversubscribed
14/11/11		45.56KB	Share
AVENotice of General Meeting and Proxy Form - 09 12 2011
03/11/11		612.85KB	Share
AVEPhosphagenics Licenses Diclofenac Gel for Indian Market
02/11/11	PRICE SENSITIVE	42.33KB	Share

REFRESH

First 3 4 5 6 7

Add to My Watchlist

What is My Watchlist?

A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.

(20min delay)
Last 0.6¢		Change 0.000(0.00%)		Mkt cap ! $19.04M

Open	High	Low	Value	Volume
0.7¢	0.7¢	0.6¢	$344	55.81K

Buyers (Bids)

No.	Vol.	Price($)
21	10913781	0.6¢

Sellers (Offers)

Price($)	Vol.	No.
0.7¢	516922	2

View Market Depth

No.	Vol.	Price($)
21	10913781	0.006
24	22125760	0.005
18	11801847	0.004
18	11475017	0.003
9	7655014	0.002

Price($)	Vol.	No.
0.007	516922	2
0.008	7751019	14
0.009	8741785	10
0.010	2198526	9
0.011	4535565	3

Last trade - 16.10pm 12/09/2025 (20 minute delay)

AVE (ASX) Chart

AVECHO BIOTECHNOLOGY LIMITED - Announcements

Announcements

Buyers (Bids)

Sellers (Offers)

Top Stories